Account
Sign In
Home
Daily Diary
Asset Class
Fixed Income
Currencies
US Equity
Specialty
Global Equity & Income
Commodities
Sectors
Healthcare
Financial Services
Basic Materials
Consumer Cyclicals
Telecom Services
Energy
Transportation
Consumer Staples
Industrials
Utilities
Technology
Real Estate
Latest
Columnist Conversation
Video
Street Notes
Authors
Bruce Kamich
Jim Cramer
Jim "Rev Shark" DePorre
Brian Sozzi
Helene Meisler
Jonathan Heller
Roger Arnold
- See All -
Options
RMPIA
Switch Product
Action Alerts PLUS
Daily Swing Trade Archive
Income Seeker
Quant Ratings
Retirement
Stocks Under $10
TheStreet
Top Stocks
Trifecta Stocks
Information Provided By:
Visit TheFly.com
TheFly.com Free Trial
Fly News Breaks for August 16, 2018
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca downgraded to Hold from Buy at Jefferies
Aug 16, 2018 | 06:04 EDT
News For AZN From the Last 2 Days
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca put volume heavy and directionally bearish
May 1, 2024 | 13:15 EDT
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
FTC expands patent listing challenges for drugs
Apr 30, 2024 | 10:13 EDT
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AIM ImmunoTech announces evaluation of first dose level in Phase 1b/2 study
Apr 29, 2024 | 08:59 EDT
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca and Daiichi Sankyo's ENHERTU improves PFS in HER2-low
Apr 29, 2024 | 07:09 EDT
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca reports results from DESTINY-Breast06 Phase 3 trial
Apr 29, 2024 | 06:31 EDT
AZN
Get Breaking Institutional Stock News For
Free
with a 14 day trial
AstraZeneca reports Truqap plus Faslodex recommended for EU approval by CHMP
Apr 29, 2024 | 06:19 EDT